Telecom Corp. of New Zealand Ltd. Ratings Remain On CreditWatch Negative Pending Proposed Demerger Of Chorus May 11

  • ID: 1806561
  • May 2011
  • Region: New Zealand
  • Standard & Poors
1 of 3

MELBOURNE (Standard & Poor's) May 27, 2011--Standard & Poor's Ratings Services said today that it had maintained its 'A' long-term and 'A-1' short-term ratings on Telecom Corp. of New Zealand Ltd. (TCNZ) on CreditWatch with negative implications, where they were initially placed on Aug. 4, 2010. This CreditWatch update follows TCNZ's announcement on May 24, 2011 that it had reached an agreement with Crown Fibre Holdings Ltd. (CFH) that would allow TCNZ's access network business, Chorus, to build and own at least 70% of the proposed "ultra fast broadband" (UFB) network in New Zealand. CFH is the government-owned entity established to facilitate the UFB process. "Importantly for creditors, the agreement with CFH would necessitate a full demerger of TCNZ's access...

Companies mentioned in this report are: Telecom Corp. of New Zealand Ltd.
Action: CreditWatch Update

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

Telecom Corp. of New Zealand Ltd.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown





Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.